Displaying 1 - 14 of 14 results
Released Company Title Industry Topic
21 Sep 2021
07:00 CEST
VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports H1 2021 Financial Results and Operational Progress 20103010 Biotechnology Commercial results
14 Sep 2021
07:00 CEST
VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. to Publish its Financial Results for H1 2021 and Operational Progress 20103010 Biotechnology Other subject
09 Sep 2021
16:41 CEST
VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V.: Vivoryon Therapeutics to Present at H.C. Wainwright 23rd Annual Global Investment Conference 20103010 Biotechnology Meetings / events
29 Jun 2021
01:11 CEST
VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Provides Update on Financial Guidance 20103010 Biotechnology Other subject
29 Jun 2021
01:03 CEST
VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics and Simcere Announce Strategic Regional Licensing Partnership to Develop and Commercialize N3pE Amyloid-targeting Medicines to Treat Alzheimer's Disease in Greater China 20103010 Biotechnology Alliances and agreements
28 Jun 2021
18:00 CEST
VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V.: Ordinary General Meeting of Shareholders of Vivoryon Therapeutics N.V. 20103010 Biotechnology General meeting / Board Meeting
25 Jun 2021
07:00 CEST
VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Announces Financial Results for the First Quarter of 2021 and Provides Corporate Update 20103010 Biotechnology Commercial results
31 May 2021
18:00 CEST
VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Reschedules Reporting of 1st Quarter 2021 and Provides Update for Annual General Meeting of Shareholders 20103010 Biotechnology Other subject
17 May 2021
07:00 CEST
VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Announces Notice of its Annual General Meeting of Shareholders to be Held on June 28, 2021 20103010 Biotechnology General meeting / Board Meeting
30 Apr 2021
07:00 CEST
VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports Full Year 2020 Financial Results 20103010 Biotechnology Commercial results
14 Apr 2021
07:00 CEST
VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reschedules the Reporting of the Full Year 2020 Financial Results to April 30, 2021 20103010 Biotechnology Other subject
01 Apr 2021
07:00 CEST
VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V.: Vivoryon Therapeutics to Host Virtual Event on Current Clinical Landscape in Alzheimer's Disease Treatment Options with Leaders and Experts on April 15th, 2021 20103010 Biotechnology Other subject
12 Mar 2021
18:02 CET
VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V.: Extraordinary General Meeting of Shareholders of Vivoryon Therapeutics N.V. 20103010 Biotechnology General meeting / Board Meeting
29 Jan 2021
18:09 CET
VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Announces Nominations to Reappoint Ulrich Dauer as CEO and to Appoint Florian Schmid as CFO 20103010 Biotechnology General meeting / Board Meeting